Europe - BIT:FDA - IT0005654683 - Common Stock
2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 17.49M | 28.61M | 24.37M | 23.84M | 21.24M | |||
Minority Interest Expense | 198.00K | 166.00K | 214.00K | 294.00K | 244.00K | |||
Cost Of Goods | 4.52M | 9.47M | 9.57M | 8.31M | 7.55M | |||
Gross Profit | 12.97M | 19.13M | 14.79M | 15.53M | 13.69M | |||
Operating Expenses | 19.16M | 20.58M | 19.23M | 17.03M | 19.02M | |||
Research and Development | 54.00K | 77.00K | 97.00K | 85.00K | 116.00K | |||
Selling, General, and Administrative Expenses | 11.93M | 12.30M | 11.43M | 10.84M | 12.42M | |||
Operating Income | -6.19M | -1.45M | -4.44M | -1.50M | -5.34M | |||
Interest Income/Expense | -2.51M | 471.00K | -259.00K | -662.00K | -224.00K | |||
Other Income/Expense | -103.00K | -48.00K | 10.73M | -1.02M | -82.00K | |||
Non Recurring Items | -385.00K | -202.00K | -488.00K | -79.00K | -399.00K | |||
Income Before Taxes | -9.18M | -1.23M | 5.55M | -3.26M | -6.04M | |||
Income Tax | 313.00K | 248.00K | -206.00K | 238.00K | -92.00K | |||
Net Income | -9.30M | -1.31M | 5.97M | -3.20M | -5.71M | |||
EBITDA | -4.85M | -164.00K | -2.30M | 432.00K | -2.63M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -32.84 | -18.85 | 86.07 | -62.62 | -111.63 | |||
Statistics | ||||||||
Gross Profit Margin | 74.17% | 66.88% | 60.70% | 65.15% | 64.43% | |||
Profit Margin | -53.17% | -4.57% | 24.49% | -13.43% | -26.88% | |||
Operating Profit Margin | -35.38% | -5.05% | -18.21% | -6.30% | -25.14% |
All data in EUR